B. Braun Medical Inc. (B. Braun) announced today the availability of large volume heparin infusion solutions. Based on the new United States Pharmacopeia (USP) standards for heparin products released ...

After the smart infusion technology was implemented, we sought to determine if the system averted errors involving infusions of heparin, a high-risk, commonly used agent. Transaction data obtained ...

18F-Fluorodeoxyglucose Positron Emission Tomography Contributes to the Diagnosis and Management of Infections in Patients With Multiple Myeloma: A Study of 165 Infectious Episodes Two hundred and ...

In 1988, Wheeler et al. [8] reported that physicians treating patients for pulmonary embolism and deep-vein thrombosis frequently underdosed their patients and were slow to change their heparin ...

A 47-year-old diabetic woman, weighing 90.5 kg, with no previous history of abnormal bleeding was diagnosed with acute myelogenous leukemia (subtype M2). She was treated with two courses of cytarabine ...